| | Title | Author(s) | Year | View Count |
| 1 |  | Assessment of the 7th AJCC staging system in prognostic stratification of resected hepatocellular carcinoma | Lo, CLR; Ng, IOL; Poon, RTP | 2012 | 72 |
| 2 | | M2 macrophages promotes tumor growth and invasion in hepatocellular carcinoma | Yeung, WH; Lee, KW; Geng, W; Li, C; Ng, KTP; Lo, CM; Guan, X; Poon, RTP; Fan, ST; Man, K | 2012 | 84 |
| 3 |  | The potential role of CD44 in liver regeneration | Lam, CT; Yang, Z; Ng, MNP; Wan, TMH; Lau, JCS; Ho, DWY; Fan, ST; Poon, RTP | 2012 | 92 |
| 4 | | Trans-arterial chemo-embolization (TACE) is safe and efficient for elderly patients with advanced hepatocellular carcinoma (HCC): Results from an international meta-database | Cohen, MJ; Levy, I; Barak, O; Bloom, AI; Fernández Ruiz, M; Di Maio, M; Perrone, F; Poon, RTP; Shouval, D; Yau, TCC; Shibolet, O | 2012 | 94 |
| 5 |  | Enhanced therapeutic efficacy of transarterial chemoembolisation treatment in hepatocelluar carcinoma (HCC) by mTOR inhibitor RAD001: implication for a novel treatment regimen in HCC | Chu, ACY; Poon, RTP; Lam, SC; Chow, KM; Pang, R | 2011 | 153 |
| 6 | | Anti-tumor efficacy of recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma | Chow, AKM; Pang, R; Chu, ACY; Ng, L; Poon, RTP; Cheng, NM | 2011 | 276 |
| 7 | | Detection of CD44+ cancer initiating cells in pleural effusion of a liver cancer patient | Chow, AKM; Poon, RTP; Ng, R; Chiu, L; Chan, S; Pang, RWC | 2011 | 133 |
| 8 | | Anti-tumor efficacy of a recombinant human arginase in combination with chemotherapeutic agents in human hepatocellular carcinoma | Chow, A; Pang, R; Chu, A; Ng, L; Poon, R | 2011 | 318 |
| 9 | | A new prognostic classification scheme with treatment guidelines for Asian patients with hepatocellular carcinoma (HCC): the Hong Kong Combined Liver Cancer (HKCLC) classification | Tang, YF; Yao, T; Yau, CC; Fan, ST; Poon, RTP | 2011 | 160 |
| 10 | | Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: a prospective, open-label, phase II study | Yau, T; Leung, RC; Wong, H; Chiu, J; Chan, P; Pang, R; Fan, ST; Poon, RTP | 2011 | 172 |
| 11 | | The use of single-agent sorafenib in the treatment of patients with advanced hepatocellular carcinoma with underlying Child-Pugh B liver cirrhosis | Chiu, J; Tang, YF; Yao, TJ; Wong, A; Wong, H; Leung, R; Chan, P; Cheung, TT; Poon, RTP; Fan, ST; Yau, CC | 2011 | 201 |
| 12 | | Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) | Finn, RS; Poon, RTP; Yau, T; Klumpen, H; Chen, L; Kang, Y; Kim, T; Gomez-Martin, C; Rodriguez-Lope, C; Kunz, T; Paquet, T; Asubonteng, K; Winkler, RE; Anak, O; Sellami, DB; Bruix, J | 2011 | 174 |
| 13 | | Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocellular carcinoma after sorafenib failure: a prospective, open-label, phase II study (Abstract) | Yau, TCC; Leung, RCY; Wong, H; Chiu, J; Chan, P; Pang, RWC; Fan, ST; Poon, RTP | 2011 | 193 |
| 14 | | Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a novel target for liver cancer therapy (Poster & Abstract) | Lu, WJ; Lee, NPY; Kaul, SC; Poon, RTP; Wadhwa, R; Luk, JMC | 2011 | 129 |
| 15 | | Tolerance of high intensity focused ultrasound ablation in patients of hepatocellular carcinoma | Cheung, TT; Poon, RTP; Lo, CM; Fan, ST | 2011 | 240 |
| 16 | | Rapid assessment of ICG by pulse desitometry: a validatory study of 70 patients | Cheung, TT; Poon, RTP; Lo, CM; Fan, ST | 2011 | 141 |
| 17 | | High intensity focused ultrasound as a bridging therapy for HCC patients on liver transplant waiting list. Hype or hope? (Plenary Session) | Cheung, TT; Chan, SC; Poon, RTP; Fan, ST; Lo, CM | 2011 | 169 |
| 18 | | Characterization of the epigenetic modification patterns of pluripotent stem cell genes in human cancers | Wang, X; Ng, RK; Ming, X; Zhang, W; Lin, C; Poon, RTP; Fan, ST | 2011 | 160 |
| 19 | | Efficacy and tolerability of Sorafenib, Capecitabine and Oxaliplatin (Secox) in patients with advanced hepatocellular carcinoma: a multi-centre phase II study (Abstract) | Yau, TCC; Chan, P; Cheung, FY; Lee, AS; Yau, TK; Choo, SP; Toh, HC; Leung, AK; Wong, JS; Wong, S; Lau, J; Pang, RWC; Fan, ST; Poon, RTP | 2011 | 235 |
| 20 | | Impact of antiviral therapy on the survival outcome of patients after major hepatectomy for hepatitis B-related hepatocellular carcinoma | Chan, ACY; Chok, K; Yuen, WK; Poon, R; Lo, CM; Fan, ST | 2011 | 210 |
Loading